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Introduc'on	  
	  	  	  	  The	  main	  goal	  of	  this	  project	  was	  to	  
educate	  peers	  on	  the	  pathophysiology	  of	  a	  
disease	  or	  disorder	  of	  choice.	  The	  topic	  to	  
be	  discussed	  is	  Polycys:c	  Ovarian	  Syndrome	  
(PCOS).	  This	  topic	  was	  chosen	  based	  on	  
personal	  interest	  in	  women’s	  health	  issues.	  
	  	  	  	  PCOS	  is	  a	  metabolic	  disease	  affec:ng	  5-­‐10	  
percent	  of	  women	  of	  childbearing	  age	  
(Morgan,	  2013).	  Polycys:c	  ovaries	  as	  
defined	  by	  Thornton,	  Von	  Wald,	  and	  Hansen	  
(2015)	  are	  12	  or	  more	  follicles	  present	  in	  at	  
least	  one	  ovary,	  measuring	  2-­‐9mm	  with	  
more	  than	  10ml	  volume.	  	  Characteris:cs	  of	  
PCOS	  include	  enlarged	  ovaries	  consis:ng	  of	  
mul:ple	  small	  cysts	  surrounding	  the	  outer	  
ovary,	  with	  unknown	  cause	  (Morgan,	  2013).	  
Leading	  to	  the	  ovaries	  producing	  an	  
increased	  amount	  of	  androgen	  (male	  
hormones)	  (Morgan,	  2013).	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•  Obesity	   	  	  
•  Excessive	  facial	  and	  body	  hair	  
•  Increased	  muscle	  size	  
•  Reduced	  breast	  size	  	  
•  Acne	  	  
•  Amenorrhea	  (absent	  
menstrual	  cycles)	  	  
•  Menstrual	  irregulari:es	  
•  Anovula:on	  
•  Hyper	  androgenism	  
•  Insulin	  resistance	  
•  Cardio-­‐metabolic	  abnormal	  
•  Ovarian	  polycys:c	  
appearance	  on	  ultrasound	  
(Morgan,	  2013)	  
	  OZerbein	  University,	  Westerville,	  Ohio 	  	  
Nursing	  Implica'ons	  
•  Be	  suppor:ve	  	  
•  Assist	  pa:ent	  in	  learning	  to	  
manage	  sugar	  cravings	  	  
•  Encourage	  exercise	  
•  Educate	  about	  an:-­‐inflammatory	  
diet	  and	  lifestyle	  
•  Refer	  pa:ents	  to	  counseling	  for	  




Polycys:c	  Ovarian	  Syndrome	  is	  more	  
than	  just	  a	  lack	  of	  menstrual	  cycles	  
and	  infer:lity.	  Long	  term	  health	  
issues	  may	  develop	  such	  as	  heart	  
disease,	  Type2	  diabetes	  and	  possibly	  
endometrial	  cancer.	  Diagnosis	  is	  
difficult	  with	  hypeprandrogenism	  
being	  a	  key	  component.	  U:lizing	  test	  
such	  as	  the	  oral	  glucose	  tolerance	  
test,	  lab	  workup,	  will	  assist	  in	  




Significance	  of	  Pathophysiology	  
•  Impaired	  glucose	  tolerance,	  insulin	  resistance	  and	  β-­‐cell	  dysfunc:on	  are	  d/t	  the	  abnormal	  glucose	  regula:on	  
increasing	  risk	  of	  Type	  2	  diabetes	  (Montplaisir,	  2011)	  
•  The	  hormone	  imbalance	  may	  lead	  to	  the	  following	  issues	  
•  Fer:lity	  issues	  	  
•  Insulin	  resistance	  	  
•  Type	  2	  diabetes	  	  
•  Hypercholesterolemia	  	  
•  Infrequent	  ovula:on	  
•  Heart	  disease	  	  
•  Greater	  risk	  HTN	  and	  cardiovascular	  disease	  
•  Sleep	  apnea-­‐	  contribu:ng	  factors	  include	  obesity,	  insulin	  resistance	  and	  hyperandrogenemia	  (DiVasta,	  p.65)	  
•  FaRy	  liver	  disease	  is	  associated	  with	  obesity,	  dyslipidemia	  and	  insulin	  resistance	  (DiVasta,	  p.65)	  
•  Increased	  risk	  of	  endometrial	  cancer	  





•  Endocrine	  disorder	  with	  reproduc:ve	  and	  metabolic	  outcomes	  (DiVasta,	  2013)	  
•  PCOS	  is	  a	  metabolic	  disease	  affec:ng	  5-­‐10	  percent	  of	  women	  of	  childbearing	  age.	  (Morgan,	  
2013.)	  	  
•  The	  condi:on	  is	  characterized	  by	  enlarged	  ovaries	  consis:ng	  of	  mul:ple	  small	  cysts	  
surrounding	  the	  outer	  ovary,	  with	  unknown	  cause	  (Morgan,	  2013).	  	  
•  Insulin	  resistance	  
•  Insulin	  s:mulates	  the	  ovaries	  to	  secrete	  androgen	  and	  decreased	  SHBG	  which	  indirectly	  
s:mulates	  testosterone	  leading	  to	  increased	  plasma	  androgen	  concentra:on	  (Montplaisir,	  
2011)	  
•  Lep:n	  levels	  are	  elevated	  which	  influences	  hypothalamic	  to	  release	  GnRH	  
•  The	  inappropriate	  gonadotropin	  secre:on	  triggers	  a	  cycle	  that	  leads	  to	  anovula:on	  
•  ↑LH	  	  
•  ↓FSH	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